Resultados obstétricos y neonatales relacionados con la hidratación intraparto en mujeres atendidas de parto de bajo riesgo / Obstetric and neonatal results associated with intrapartum hydration for women with low-risk labour

Objetivo: determinar la influencia de la hidratación intraparto en los resultados obstétricos y neonatales en mujeres nulíparas atendidas por parto de bajo riesgo.Métodos: se realizó un estudio observacional prospectivo en el Hospital Universitario Puerta de Hierro Majadahonda (Madrid, España). Se incluyeron mujeres nulíparas con gestación única atendidas por parto de bajo riesgo. Se recogieron variables maternas (sociodemográficas, clínicas al ingreso, intraparto y en el puerperio inmediato, resultados obstétricos) y neonatales (datos al nacimiento, a las 24 y 48 horas). Se realizó análisis descriptivo y univariante con los test estadísticos correspondientes. Se valoró la influencia de la hidratación en los resultados obstétricos y neonatales estableciendo un punto de corte en la hidratación recibida intraparto (mediana volumen total administrado por hora: 300 mL/h).Resultados: se incluyeron 148 mujeres. Edad media (DE) 32 (4,4) años, edad gestacional media (DE) 39 (1,4) semanas. Al ingreso, la dilatación media fue de 2 cm. Parto inducido en 65,5% (n= 97). Los resultados obstétricos y neonatales fueron más favorables en las mujeres que recibieron un volumen mayor(> 300 mL/h), con diferencias significativas en la duración total del parto (mediana 526 vs. 735 min; p< 0,001), incidencia de parto por cesárea (14,3% frente 18,7%), fiebre (5,5% frente a 7,7%), incidencia de pérdida de peso neonatal superior al 7% a las 48 horas (28,6% frente a 39,8%), lactancia materna (94,6% frente a 82,4%).Conclusiones: la administración de un mayor volumen de líquidos a mujeres nulíparas durante el parto de bajo riesgo se asoció con mejores resultados obstétricos y neonatales.(AU)

Objective: to determine the influence of intrapartum hydration on obstetric and neonatal results in nulliparous women during low-risk labour.Methods: an observational prospective study was conducted at the Hospital Universitario Puerta de Hierro Majadahonda (Madrid, Spain). The study included nulliparous women with single pregnancy and low-risk labour. Maternal variables were collected (sociodemographic, clinical signs at admission, intrapartum and immediately post-partum, obstetric results) as well as neonatal variables (data at birth, at 24 and 48 hours). Descriptive and univariate analysis was conducted with the relevant statistic tests. The influence of hydration was assessed in obstetric and neonatal results, determining a cut-off point for the hydration received intrapartum (median total volume administered per hour: 300 mL/h).Results: the study included 148 women, with a mean age (SD) of 32 (4.4) years, and a mean gestational age (SD) of 39 (1.4) weeks. At admission, mean dilation was of 2 cm. There was induced labour in 65.5% of cases (n= 97). Obstetric and neonatal results were more favourable in those women who received a higher volume (≥ 300 mL/h), with significant differences in the total duration of labour (median 526 vs. 735 min; p< 0.001), incidence of Caesarean births (14.3% vs. 18.7%), fever (5.5% vs. 7.7%), incidence of neonatal weight loss >7% at 48 hours (28.6% vs. 39.8%), breastfeeding (94.6% vs. 82.4%).Conclusions: administration of a higher volume of fluids to nulliparous women during low-risk labour was associated with better obstetric and neonatal results.(AU)

Efficacy of "optimal hydration" during labor: HYDRATA study protocol for a randomized clinical trial.

There is a lack of consensus in the international scientific community with respect to the most suitable hydration strategies when attending nulliparous women during low-risk births. This paper describes the protocol for a randomized controlled trial to compare two hydration strategies and their influence on maternal and neonatal morbidity. The study population consists of nulliparous women admitted to the obstetrics department of a University Hospital. The women are being randomized into two groups: the "optimal hydration" group, which will be guaranteed 300 ml/hr liquids (crystalloids and bottled mineral water) with a minimum diuresis of 35 ml/hr; and the "variability in hydration" group, which will receive intravenous (alternating normal saline, Ringer's lactate solution, glucose, or Voluven®) and clear (bottled mineral water or isotonic drinks [Aquarius®]) liquids, without any established perfusion rate, and without established minimum diuresis. Outcomes for mothers include duration of labor, cesarean section, fever, and dehydration. Outcomes for newborns are respiratory distress, hypoglycemia, hyponatremia, jaundice, weight loss over 48 hr, and breastfeeding difficulties. Analysis will be per-protocol. Administering optimal hydration may improve health and safety for mothers and their newborn and reduce maternal and neonatal morbidity. The study is registered at www.clinicaltrials.gov. The project received funding by the Ministry of Health of Spain and is approved by the Research Ethics Committee.

Cessation of breastfeeding in association with oxytocin administration and type of birth. A prospective cohort study.

BACKGROUND: Some studies have suggested an association between synthetic oxytocin administration and type of birth with the initiation and consolidation of breastfeeding. AIM: This study aimed to test whether oxytocin administration and type of birth are associated with cessation of exclusive breastfeeding at different periods. A second objective was to investigate whether the administered oxytocin dose is associated with cessation of exclusive breastfeeding. METHODS: We conducted a prospective cohort study (n=529) in a tertiary hospital. Only full-term singleton pregnancies were included. Four groups were established based on the type of birth (vaginal or cesarean) and the intrapartum administration of oxytocin. Follow-up was performed to evaluate the consolidation of exclusive breastfeeding at 1, 3 and 6months. FINDINGS: During follow-up, the proportion of exclusive breastfeeding decreased in all groups. After adjusting for confounding variables, the group with cesarean birth without oxytocin (planned cesarean birth) had the highest risk of cessation of exclusive breastfeeding (odds ratio [95% confidence interval], 2.51 [1.53-4.12]). No association was found between the oxytocin dose administered during birth and puerperium period and the cessation of exclusive breastfeeding. CONCLUSION: Planned cesarean birth without oxytocin is associated with the cessation of exclusive breastfeeding at 1, 3 and 6months of life. It would be desirable to limit elective cesarean births to essentials as well as to give maximum support to encourage breastfeeding in this group of women. The dose of oxytocin given during birth and puerperium period is not associated with cessation of exclusive breastfeeding.

A Comparison of Factors Associated with Cessation of Exclusive Breastfeeding at 3 and 6 Months.

AIM: To analyze the association of labor and sociodemographic factors with cessation of exclusive breastfeeding (EBF) at 3 and 6 months of life. MATERIALS AND METHODS: A prospective cohort study (n = 529) was performed in a tertiary hospital with the Baby-Friendly Hospital Initiative (BFHI) award. Labor and sociodemographic factors were investigated. Single-term newborns were included. After 3 and 6 months, telephone calls were made to determine the type of lactation. Univariate analysis was performed with the chi-square test or Fisher's exact test. Multivariable logistic regression models were developed to determine risk factors associated with cessation of breastfeeding at 3 and 6 months. RESULTS: At 3 months, 523 participants (98.9%) were contacted, of whom 64.4% maintained EBF. Factors associated with cessation were pacifier use (odds ratio [OR] 3.49; 95% confidence interval [95% CI] 2.24-5.43), cesarean delivery (OR 4.49; 95% CI 2.96-6.83), no college degree (OR 2.01; 95% CI 1.35-3.01), and not attending breastfeeding support groups (OR 1.96; 95% CI 1.22-3.12). At 6 months, 512 participants (96.8%) were contacted, of whom 31.4% maintained EBF. Factors associated with cessation were reintegration into the workplace (OR 4.49; 95% CI 2.96-6.83), pacifier use (OR 3.49; 95% CI 2.24-5.43), and primiparity (OR 1.61; 95% CI 1.05-2.46). CONCLUSIONS: Several risk factors are associated with the premature cessation of EBF. There is a need to define strategies to correct modifiable factors and to promote protective factors with the aim of improving the success rate of EBF to reach the recommendations of the World Health Organization.